SANTA CRUZ DE TENERIFE, Sep 7 (EUROPA PRESS) –
The Ministry of Health of the Government of the Canary Islands informs this Tuesday that 1,566,093 people have already been immunized who have already received the complete vaccination schedule, which represents 79.87 percent of the target population of the archipelago.
If the initial target population – those over 16 years of age – in the Canary Islands is taken as a reference, 83.70 percent are already immunized.
In total, the Nursing teams of the Canary Health Service have administered 3,040,562 doses of vaccines against COVID-19.
In the Archipelago, 83.49 percent of the target population (that of more than 12 years that amounts to 1,960,774 people) is already vaccinated against COVID-19, since there are already 1,637,139 people who have received, at least one dose of the vaccine.
This means that 87.50 percent of those over 16 years of age (who were the target population when the campaign began) have at least one dose.
At present, groups from 1 to 7 (residents and health and social health personnel of residences; health personnel; large dependents and main caregivers; vulnerable people; groups with essential functions such as teachers and police officers and people with very high-risk conditions) are they are already vaccinated with two doses between 99.5 and 100%.
Group 8, people between 60 and 65 years old, has 82.71 percent with at least one dose and 63.02 percent with a complete regimen and group 9, people between 50 and 59 years old, with 95 , 66% with at least one dose and 96.23% with the complete regimen.
Regarding group 10, corresponding to people between 40 and 49 years old, 59.45 percent have at least one dose and 76.95 percent have a complete regimen (they include those immunized with Janssen, which is a single-dose vaccine). dose).
In group 11, people between 30 and 39 years old, 63.98 percent have at least one dose and 58.81 percent, complete regimen.
For people between 20 and 29 years old (group 12), 59.09 percent have a dose and 53.37 percent, complete regimen, and group 13 – between 12 and 19 years old – with a 73.36% with one dose and 62.63% with the complete regimen.
